An experimental model to induce metabolic syndrome in Rats. The fructose-enriched diet

Farmacia

Volumn 61, Issue 2, 2013, Pages 420-426

  Ghibu, Steliana ^a   Decea, Nicoleta ^a   Morgovan, Claudiu ^b   Mogosan, Cristina ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b VASILE GOLDIS WESTERN UNIVERSITY OF ARAD   (Romania)

Author keywords

Metabolic syndrome; Rat fructose enriched diet; Research animal model

Indexed keywords

FRUCTOSE; GLUCOSE; MALONALDEHYDE; TRIACYLGLYCEROL;

ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIET; LIPID PEROXIDATION; MALE; METABOLIC SYNDROME X; NONHUMAN; OXIDATIVE STRESS; RAT; SYSTOLIC BLOOD PRESSURE;

EID: 84876006624     PISSN: 00148237     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006; 23(5):469-480.
2. Day C. Metabolic syndrome, or What you will: definitions and epidemiology. Diab Vasc Dis Res. 2007; 4(1):32-38.
3. Esterbauer H. and Cheeseman K. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol, 1994; 186:406-413.
4. Holvoet P. Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease. Verh K Acad Geneeskd Belg. 2008; 70(3):193-219.
5. Korandji C, Zeller M, Guilland JC, Collin B, Lauzier B, Sicard P, Duvillard L, Goirand F, Moreau D, Cottin Y, Rochette L, Vergely C. Time course of asymmetric dimethylarginine (ADMA) and oxidative stress in fructose-hypertensive rats: a model related to metabolic syndrome. Atherosclerosis. 2011; 214(2):310-315.
6. Leão LS, Moraes MM, Carvalho GX, Koifman RJ. Nutritional interventions in Metabolic Syndrome: a systematic review. Arq Bras Cardiol. 2011; 97(3):260-265.
7. Pepene CE, Ilie IR, Marian I, Duncea I. Circulating osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in polycystic ovary syndrome: relationships to insulin resistance and endothelial dysfunction. Eur J Endocrinol. 2011; 164(1):61-68.
8. Roche HM, Phillips C, Gibney MJ. The metabolic syndrome: the crossroads of diet and genetics. Proc Nutr Soc. 2005; 64(3):371-377.
9. Russell JC, Proctor SD. Small animal models of cardiovascular disease: tools for the study of the roles of metabolic syndrome, dyslipidemia, and atherosclerosis. Cardiovasc Pathol. 2006; 15(6):318-330.
10. Virgolici B., Mohora M., Radoi V., Lixandru D., Stoian I., Gaman L., Coman A., Greabu M., Begona Manuel-Y-Keenoy, Correlations between dysglycemia, markers of oxidative stress and inflammation in diabetic foot patients, Farmacia, 2011, 59(2), 216-227
11. Stanhope KL, Havel PJ. Fructose consumption: recent results and their potential implications. Ann N Y Acad Sci. 2010; 1190:15-24.
12. Tran LT, Yuen VG, McNeill JH. The fructose-fed rat: a review on the mechanisms of fructose-induced insulin resistance and hypertension. Mol Cell Biochem. 2009; 332(1-2):145-159.
13. Miricescu D., Greabu M., Totan A., Mohora M., Didilescu A., Mitrea N., Arsene A., Tudor Spinu, Cosmin Totan, Radu Rǎdulescu, Oxidative stress-a possible link between systemic and oral diseases, Farmacia, 2011, 59(3), 329-337
14. Vazquez-Vela ME, Torres N, Tovar AR. White adipose tissue as endocrine organ and its role in obesity. Arch Med Res. 2008; 39(8):715-728.
15. Wiernsperger N, Geloen A, Rapin JR. Fructose and cardiometabolic disorders: the controversy will, and must, continue. Clinics (Sao Paulo). 201l; 65(7):729-738.